In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial.

Atsushi TanakaKeisuke KidaYuya MatsueTakumi ImaiSatoru SuwaIsao TaguchiItaru HisauchiHiroki TeragawaYoshiyuki YazakiMasao MoroiKoichi OhashiDaisuke NagatomoToru KubotaTakeshi IjichiYuji IkariKeisuke YonezuNaohiko TakahashiShigeru ToyodaTsutomu ToshidaHiroshi SuzukiTohru MinaminoKazutaka NogiKazuki ShiinaYu HoriuchiKengo TanabeDaisuke HachinoheShunsuke KiuchiKenya Kusunose Michio Shimabukuro Koichi Node

Published in: European heart journal (2024)

ClinicalTrial.gov (NCT05164653) and Japan Registry of Clinical Trials (jRCTs021210046).

Keyphrases

acute heart failure
clinical trial
phase ii
phase iii
heart failure
study protocol
open label
angiotensin converting enzyme
angiotensin ii
healthcare
acute care
double blind
adverse drug
randomized controlled trial
binding protein
atrial fibrillation